International GastroIntestinal, Liver & Uro-Oncology Conference … · 2020-05-04 · 10 9 th International GastroIntestinal Liver & Uro-Oncology Conference Prof. Gengis Yakicier

16-17 APRIL

2020 JW MARRIOTTCAIRO - EGYPT

9th International GastroIntestinal,Liver & Uro-Oncology Conference

WW

W.IG

ILUC

.CO

M

II LInternational GastroIntestinal, Liver & Uro-Oncology Conference

CALL FOR ABSTRACTS CAL

L FO

R AB

STRA

CTS CALL FOR ABSTRACTS CALL FO

R ABSTRACTS

CALL

FOR

ABSTRACTS

Egyptian Society of Interventional Radiology

Faculty of Medicine AinShams Research Institute

Prof. Waheed YousryProf. of Surgical Oncology

NCI - Cairo University

Prof. Osama HettaProf. of Radiology

Ain Shams University

Prof. Tarek OsmanProfessor of Urology,Ain-Shams University

Prof. Hesham El-GhazalyProf. of Clinical oncology


Personalization

Precision

& Perfection

Prof. Mahmoud El-MeteiniProf of Surgery and Liver transplantPresident of Ain Shams University

IInternational Collaboration has been the theme for the IGILUC from its first edition and this year, we will underpin the need for collaboration and cooperation in implanting cancer control strategies, exchange of experience on cancers &networking with colleagues from around the world ,collaborating with international societies and high caliber international experts to make cancer history; the driving force behind this collaboration is the shared mission of the organizations and scientists to advance progress against cancer

Gastrointestinal cancers and the accessory organs of digestion (pancreas, liver, gall bladder) are responsible for more cancers and more deaths from cancer than any other system in the body. There is significant geographic variation in the rates of different gastrointestinal cancers.

Liver tumors has the fastest growing death rate of all cancers in the world so we need discussion of the prospects in the

context of the most recent international trends and initiatives for the treatment.

Personalization

Precision

& Perfection

L

C

Urological Tumors include cancers of the bladder, kidney, prostate and testicles, all relatively common. Prostate cancer, for example, is the most common cancer in men. multimodal team for the surgery, radiation and chemo therapy as well as the post treatment long-term follow-up care is required for research professional that need to gather in a challenge for future eradication of cancer.

Conference›s Scientific Program is designed to provide state-of-the-art Information on GU and GI topics , issues; offering breakthrough advances and insight in scientific and clinical research, patient management and practice through an outstanding range of scientific and educational symposia, special sessions, teaching lectures, workshops, debates and much more. A comprehensive, stimulating and highly-educational scientific experience is guaranteed for all.

International GastroIntestinal,Liver & Uro-Oncology Conference

9th International GastroIntestinal, Liver & Uro-Oncology Conference4

CONFERENCE BOARDUnder Patronage

Chairmen of the Scientific Committee (Alphabetical)

Prof. Hala ZayedMinister of Health and Population

Prof. Khaled Abdel GhaffarMinister of High Education

Prof. Mohamed Fathy Professor of SurgeryAin-Shams University

Prof. Waheed Y. GareerProfessor of Surgery

Cairo University

Prof. Hussein OkashaProf of Internal Medicine and Gastroenterology

.Cairo University

GENERAL SECRETARY & CHAIRMAN OF SCIENTIFIC COMMITTEE

Prof. Hesham ElghazalyProfessor of clinical oncology

Ain Shams university

CONFERENCE COORDINATOR

Dr. Ahmed Mesbah Dr. Ramy Barkah Dr. Karem Nagi

Scientific coordinators

Prof. Mahmoud EI-MeteiniPresident of Ain shams University

Prof. Ashraf OmarDean of Faculty of Medicine


Prof. Abdel Aziz BelalChairman of clinical oncology department

Alexandria university

Prof. Ahmed MorsiChairman of Surgical oncology

NCI Cairo University

Prof. Alaa KandilProfessor of clinical oncology department


Prof. Ashraf OmarProfessor of Tropical Medicine

Cairo University

Prof. Mohamed AbdallahProfessor of Clinical oncology

Cairo University

Prof. Ibtessam Saad AldinProfessor of Clinical oncology

Cairo University

Prof. Mohamed K. ShakerChairman of HCC Society


Prof. Nasr El LahlobyProfessor of Medical oncology

NCI Cairo university

Prof. Osman MansourChairman of Medical oncology

NCI Cairo University

Prof. Samir ShehataProfessor of clinical oncology department

Assiut university

Prof. Tarek HashemProfessor of Clinical Oncology

Mounifia University

Prof. Waleed HettaProfessor of interventional Radiology


Prof. Ashraf ZaghlolProfessor of Surgical oncology

NCI Cairo university

Prof. Gamal El HusseinyProfessor of clinical oncology department


Prof. Hesham BadawyProfessor of Urology department

Cairo University

Prof. Mohamed El-GamalChairman of Urology department

Cairo University

HONORARY PRESIDENTS

PRESIDENTS

Prof. Hussein KhaledProfessor of medical oncology, NCI

Ex-minister of higher education

Prof. Ahmed ElDorryProfessor of radiologyAin Shams University

Prof. Hatem AboelkasemProfessor of Surgical oncology

Dean NCI Cairo university

Prof. Yaser Abdel KaderProfessor of clinical oncology,

Cairo University

Prof. Emad HamadaChairman of clinical oncology department

Cairo University

Prof. Manal MoawadProfessor of clinical oncology department


Prof. Osama HettaProfessor of RadiologyAin Shams university

Prof. Heba EI Zawahry Professor of Medical oncology

NCI, Cairo university

Prof. Waheed Y. GareerProfessor of Surgical Oncology, NCI

Honrary President of EgyptianSociety of Surgical Oncology

Prof. Ehab MostafaChairman of clinical oncology department


Prof. Hamdy Abdel AzimProfessor of Clinical Oncology

Cairo University

Chairmen of Workshops

Prof. Osama HettaProfessor of Interventional Radiology


Prof. Mohamed Abou El FotouhProfessor of Clinical Oncology

Menoufia University

Prof. Khaled Abdel KreemProfessor of Clinical Oncology


Prof. Mohammed FaroukProfessor of clinical oncology


Prof. Mohamed YassinProfessor of clinical oncology

Ain shams university

Prof. Mai Ezz EldinProfessor of clinical oncology


Dr. Nermean MostafaLecturer of clinical oncology


Prof. Tarek OsmanProfessor of UrologyAin-Shams University

Prof. Hany MostafaChairman of Urology department


9th International GastroIntestinal, Liver & Uro-Oncology Conference 5

Personalization

Precision

& Perfection

Prof. Heinz-Josef Lenz Professor of Medicine and Preventive Medicine Associate Director, Clinical Research Chair, GI Oncology Program Co-director, Colorectal Center Scientific director, Cancer Genetics Unit at the USC Norris Comprehensive Cancer CenterHead of GI Oncology in the Division of Medical Oncology and Co-Director of the Colorectal Center at the Keck School of Medicine of the University of Southern California.

Prof. David H. Ilson Attending physician and member at Memorial Sloan Kettering Cancer CenterProfessor of medicine at Weill Cornell Medical CollegeMember of the GI committees of the national clinical research groups Cancer and Leukemia Group B (CALGB) and Radiation Therapy Oncology Group (RTOG)Member of the Upper GI Cancer Guidelines Committee of National Comprehensive Cancer Network (NCCN)Chairman of the Intergroup Esophageal and Gastric Cancer Task Force Committee

Prof. Axel GrotheyConsultant at the West Cancer Center, University of Tennessee, in Memphis, TN Chaired the Academic and Community Cancer Research United (ACCRU) international research network

Prof.Jan SchmidtProfessor of Visceral , Hepatobiliary ,Pancreatic and Transplantation Surgery .Swiss Surgery Center ,Hirslanden Hospital Zurich , Switzerland

Prof. Ahmed Kaseb Professor, Department of Gastrointestinal (GI) Medical Oncology,Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX



Prof. Nicolas MottetUniversity Hospital St. Etienne, UrologySt. Etienne, FranceHead of the Urology Department, University Hospital, and Professor of Surgery, University Jean Monnet, Saint-Etienne,France

Prof. Jorge A. GarciaMD, FACPThe Kerscher Family Chair for Clinical Prostate Cancer Research at the Cleveland Clinic.A staff physician and member of the Department of Hematology and Oncology and Urology at the Cleveland Clinic’s Taussig Cancer Institute and Glickman Urological & Kidney Institute.

Prof. Claude AbbouProfessor of the Universities (section Urology), University ParisChairman of the Oncology DepartmentFormer Chairman of Oncology Group for Guidelines European Urological Association.

Prof. Mack Roach IIIMD, FACR, FASTROProfessor Radiation Oncology and Urology Director, Particle Therapy Research Program & OutreachDepartment of Radiation Oncology UCSF Helen Diller Family Comprehensive Cancer Center

Prof. Eleni EfstathiouMD, PhDAssociate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX


Personalization

Precision

& Perfection

Prof. Riad SalemVice Chair for Image Guided Therapy, Department of RadiologyChief of Vascular Interventional Radiology in the Department of RadiologyProfessor of Radiology, Medicine (Hematology and Oncology) and Surgery northwestern university, feinberg school of medicine , chicago, USA

Prof. Ali Shams EldinDirector of Gastrointestinal and GenitourinaryCancer Program AUBMC(LEBANON)

Prof. Thiaerry De BaereHead of Department of Interventional Radiology at Institut Gustave Roussy .

Prof. Masatoshi KudoProfessor and ChairmanDepartment of Gastroenterology and HepatologyKindai University Faculty of Medicine

Prof. Jon BellConsultant Interventional Radiologist, The Christie NHS Foundation TrustUK



Prof. Amr Fergany MD, laparoscopic surgery and urologic oncology with the Glickman Urological and Kidney Institute at Cleveland Clinic›s main campus.

Prof. Martin CiupaChief Artificial Intelligence Officer, MindmazeSwitzerland

Prof. Axel Merseburger Professor and Chairman of the Department of UrologyCampus Lübeck,University Hospital Schleswig-Holstein, Germany.

Prof. Stephane OudardMedical Oncology Head of service Georges pompidou Hospital, Paris

Prof. Yasuaki AraiDirector, National Cancer Center Hospital Tokyo, JapanPresident of Japanese Society of Interventional Radiology (JSIR)


Personalization

Precision

& Perfection

Prof. Neil barberConsultant Urological Surgeon inCentral London FarnhamWoking & Frimley BSc FRCS(Urol)

Prof. Fady GearaProfessor and Chairman, Department of Radiation Oncology, Founding Director, The Naef K Basile Cancer Institute (2012-2007) American University of Beirut Medical Center, Beirut, Lebanon

Prof. Mohamed AltwalahInterventional radiology consultantDABR, CAQ, Riyadh.Head of Scientific Committee PAirs

Prof. Sunil KrishnanProfessor, Department of Radiation Oncology, Divisionof Radiation Oncology, The University of Texas MDAnderson Cancer Center, Houston, TX



Prof. Gengis Yakicier Head of Molecular Biology and Genetic Daprtment Acebadim UniversityTurkey

Prof.Ahmed SultanAdjunct Professor, Oncology Department, LCCC, Georgetown University Medical Center,Washington DC, USA

Prof. Sami KhatibSecretary General of AMAAC (Arab Medical Association Against Cancer), Jordan

Prof. Amr EmaraConsultant Urologist at Hampshire Hospitals NHS Foundation Trust , Basingstoke, Hampshire, United Kingdom , Hospital & Health Care

Prof. Philip RoweSchool of Pharmacy & Biomolecular Sciences

UK


Personalization

Precision

& Perfection

MainTopics

Cancer of the PancreasGenetics and molecular alterations in pancreatic cancerAre we making progress in surgery of the pancreas?Adjuvant and neoadjuvant treatment options in resectable pancreatic cancerImproving the outcomes of patients with metastatic pancreatic cancer Bile Duct CancerMolecular alterations in bile duct cancerNew agents and strategies on the horizon in bile duct cancerThe management of locally advanced bile duct cancer

Esophageal and Gastric CancersDefinitive CRT or neoadjuvant therapy followed by surgery in esophageal cancerLocally advanced GE junction cancer: CRT or perioperative CTSurgery in oligometastatic gastric cancer?Where are we with checkpoint inhibitors in metastatic gastric cancer?New targeted agents in metastatic gastric cance

Hepatocellular CarcinomaHow to integrate new agents in HCCLocoregional treatment for HCCMultidisciplinary tumor board on HCC

Multimodality Therapy for Rectal CancerImaging in rectal cancerRectal cancer after neoadjuvant therapy with complete clinical response: Surgery or watchful waitingNew evolutions and ideas in surgeryAdjuvant chemotherapy or neoadjuvant chemotherapy in rectal cancer

Keynote LecturesNovel Immuno-Oncology mechanisms and approaches in GI cancers: Where are we?Multidisciplinary Tumor BoardsThe challenging patient with NETThe challenging patient with Gastric cancerRenal Cell Carcinoma ConsensusUpdating HCC recommendations workshopColorectal CancerUpdates on treatment algorithms in metastatic CRC in 2020Early stage colon cancer current and future practiceCan we refine the selection for adjuvant treatment in stage II colon cancer?How to improve the results with IO agents in MSI CRClink between immune micro inviroment and outcome of CRCRole of NGS testing in mCRC

GenitoUrological (GU) tumors • Radiotherapy for prostate cancer beyond local treatment• Novel combination therapies for bladder cancer• Metastasectomy and cytoreductive nephrectomy in the targeted therapy era• Is genomic classification going to help in RCC?• Management of M0 patient with rising PSA• Multimodality treatment for hormone-naïve metastatic prostate cancer• Pelvic radiotherapy and local radiotherapy in metastasized disease• Sequential vs. combination therapy: how to maximize benefit from hormonal agents• Castration resistant prostate cancer urological point of view and oncological point of view.• Immunotherapies in Urothelial malignancies• Novel systemic therapy including immunotherapy for the treatment of advanced RCC• Checkpoint inhibitors in prostate cancer



Topics

Meet International and international IR(Interventional Radiology)

Director of Workshops Coordintor of WorkshopsProf. Osama HettaProf of interventionalRadiologyAin Shams University

Prof. Waleed HettaProf of interventional RadiologyAin Shams University

Prof. Yasuaki AraiDirector, National Cancer Center Hospital Tokyo, JapanPresident of Japanese Society of Interventional Radiology (JSIR)

• Radio-frequancy ablationof benigne thyroid nodules• Hands on angio-cath simmulator for chemo-embolization , prostatic embolization and uterine artery embolization for fibroids• State of the art lectures by international experts in updates of locoregional man agement of HCC and metastatic liver disease. • Challenging case presentations in field of IR (Interventional Radiology) and discussion by national and international experts. • Debates in interventional oncology hot topics.• Urological tumors; can IR (Interventional Radiology) share in treatment? • HCC panel discussion and recommendations.• GI bleeding; does IR (Interventional Radiology)have a role?• Bone tumors and painful bony metastasis; can IR (Interventional Radiology)solve the problem?• Oligometastatic disease ; Role of Interventional radiolgy.• Embolotheraby in HCC.• HCC with extra hepatic disease; is there still a role for IR.

Prof. Riad SalemVice Chair for Image Guided Therapy, Department of RadiologyChief of Vascular Interventional Radiology in the Department of RadiologyProfessor of Radiology, Medicine (Hematology and Oncology) and Surgery northwestern university, feinberg school of medicine , chicago, USA

Prof. Thiaerry De BaereHead of Department of Interventional Radiology at Institut Gustave Roussy .

Prof. Mohamed AltwalahInterventional radiology consultantDABR, CAQ, Riyadh.Head of Scientific Committee PAirs

Course Director and International Experts

Prof. Jon BellConsultant Interventional Radiologist, The Christie NHS Foundation TrustUK


Personalization

Precision

& Perfection

Course Directors

Topics

Prof. Tarek OsmanProfessor of Urology,Ain-Shams University

Prof. Amr EmaraConsultant Urologist at Hampshire Hospitals NHS Foundation Trust , Basingstoke, Hampshire, United Kingdom , Hospital & Health Care

Uro-Oncology Program and Hands On Workshop

- Advanced Prostate cancer current status and future directions- Prostate Cancer Metastasis Directed therapy- New anti-androgens myths and reality- Surgery in the advanced disease - Focal therapy for prostate cancer and novel directions

- Renal cell carcinoma the role of surgery in the era of TKI - Minimally invasive treatment for RCC - Radical Cystectomy and Chemotherapy which is first?- New directions in management of non muscle invasive bladder cancer- Endourology Workshop

Prof. Amr Fergany MD, laparoscopic surgery and urologic oncology with the Glickman Urological and Kidney Institute at Cleveland Clinic›s main campus.

Prof. Nicolas MottetUniversity Hospital St. Etienne, UrologySt. Etienne, FranceHead of the Urology Department, University Hospital, and Professor of Surgery, University Jean Monnet, Saint-Etienne,France

Prof. Claude AbbouProfessor of the Universities (section Urology), University ParisChairman of the Oncology DepartmentFormer Chairman of Oncology Group for Guidelines European Urological Association.


Prof. Jorge A. GarciaMD, FACPThe Kerscher Family Chair for Clinical Prostate Cancer Research at the Cleveland Clinic.A staff physician and member of the Department of Hematology and Oncology and Urology at the Cleveland Clinic’s Taussig Cancer Institute and Glickman Urological & Kidney Institute.

Prof. Hany MostafaChairman of Urology DepartmentAin Shams University

Prof. Neil barberConsultant Urological Surgeon inCentral London FarnhamWoking & Frimley BSc FRCS(Urol)

Featuring for the first time the National Uro-Oncology Competition

Prof. Stephane OudardMedical Oncology Head of service Georges pompidou Hospital, Paris

Prof. Eleni EfstathiouMD, PhDAssociate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Prof. Axel Merseburger Professor and Chairman of the Department of UrologyCampus Lübeck,University Hospital Schleswig-Holstein, Germany.



Hands on EndoscopyMeet Experts Workshop

Interventional radiology workshop

GLASS ROOM


Personalization

Precision

& Perfection

Differential diagnosis of solid pancreatic lesions Role of EUS in detection of solid pancreatic malignant lesions Mimics of cancer pancreas Role of EUS in staging of malignant pancreatic masses Tissue acquisition of pancreatic masses Cytopathology of pancreatic lesions Video cases of different solid pancreatic lesions Differential diagnosis of cystic pancreatic lesions Role of EUS in cystic pancreatic neoplastic lesions Mimics of cystic pancreatic neoplasms Cytopathology of cystic pancreatic lesions Video cases of different cystic pancreatic lesions 1st Hands on session, EUS-FNA Role of EUS in staging and impact on management of esophageal malignancyRole of EUS in staging and impact on management of gastric malignancyRole of EUS in staging and impact on management of rectal malignancy Role of EUS diagnosis of endoscopic biopsy negative GI malignancy Role of EUS in diagnosis of submucosal tumors Role of EUS in management of submucosal tumorsVideo cases

Course Director

Prof. Hussein OkashaProf of Internal Medicine and GastroenterologyCairo University.

HCV and v Course

Topics

Course Director and International Expert



Radiation Oncology Course

- Basic Clinical Radiobiology - Target Volume Determination –From Imaging to Margins- Image Guided Radiation Oncology in Clinical Practice - Upper GI – Technical and clinical Challenges for Radiation Oncologists - Hepatocellular Carcinoma : Technical and clinical Challenges for Radiation Oncologists- Localized Prostate Cancer : Multidisciplinary management - Role of Radiation therapy in context of Low volume metastatic Prostate Cancer - Bladder Sparing Chemo-Radiation :What are the advantages - Quality and safety measures in the delivery of radiation Therapy.- Comprehensive and Practical Brachytherapy- Particle Therapy

Prof. Mohamed Abou El FotouhProfessor of Clinical OncologyMenoufia University

Prof. Khaled Abdel KreemProfessor of Clinical OncologyAin Shams University

Topics

Prof. Fady GearaProfessor and Chairman, Department of Radiation Oncology, Founding Director, The Naef K Basile Cancer Institute (2012-2007) American University of Beirut Medical Center, Beirut, Lebanon

Prof. Mack Roach IIIMD, FACR, FASTROProfessor Radiation Oncology and UrologyDirector, Particle Therapy Research Program & OutreachDepartment of Radiation Oncology UCSF Helen Diller Family Comprehensive Cancer Center

Prof. Sunil KrishnanProfessor, Department of Radiation Oncology, Divisionof Radiation Oncology, The University of Texas MDAnderson Cancer Center, Houston, TX



Personalization

Precision

& Perfection

Surgical Oncology Topics:- Gastric cancer - Pancreatic cancer- Gastrointestinal Stromal Tumors - Colorectal Cancer- HCC - Liver Transplantation for HCC- Laparoscopic colorectal surgery - Upper GI minimal invasive surgery- Robotic Assisted minimal invasive surgery - CRS and HIPEC in GI malignancies- Cytoreductive Surgery and HIPEC in GI peritoneal metastasis- Post operative Complications and Management

Minimally invasive (Robotic and Laparoscopic) GI Surgery Course (Endorsed by ESSO)

Prof. Waheed Y. GareerProf of Surgical Oncology at National Cancer Institute, Cairo, Egypt

Course Director


Prof.Jan SchmidtProfessor of Visceral , Hepatobiliary ,Pancreatic and Transplantation Surgery .Swiss Surgery Center ,Hirslanden Hospital Zurich , Switzerland




Personalization

Precision

& Perfection

Artificial intelligence in cancer manegment

Prof. Martin CiupaChief Artificial Intelligence Officer, MindmazeSwitzerland

- AI in healthcare in scope of diagnosis, management, and the development of effective therapies

- Big data archetecture, access and processing

- Health care Data visualization and analysis

- Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives

- The existing solutions of AI and their limitations in cancer genetic testing and diagnosticsHow AI is shaping the future of Bioinformatics

Prof. Hesham El-GhazalyProf. of Clinical oncologyAin Shams University



Analysing the Innovation & Future Trends in Genomics and Molecular Biology

Cancer genomicsTumour Genomics is the investigation of hereditary transformations in charge of malignancy, utilizing genome sequencing and bioinformatics. Disease genomics is to enhance growth treatment and results lies in figuring out which sets of qualities and quality associations influence diverse subsets of tumors.

Target audience IGLUC 2020 Molecular course will be relevant to participants from across a number of fields including clinical pathology, systems biology, bioinformatics, artificial intelligence, cancer medicine, translational research, epigenomics, cancer immunology and molecular pathology. Importantly, early career researchers will have the opportunity to present their work to the international community.

Topics to be covered :- DIFFERENTIAL PARTITIONING OF CANCER THERAPEUTICS IN NUCLEAR CONDENSATES.- TRANSCRIPTOME-WIDE DISTRIBUTION AND FUNCTION OF RNA MODIFICATIONS.- REGULATION OF THE CODING AND NONCODING GENOME BY INTEGRATOR.- IMPACT OF HETEROCHROMATIN REGULATION IN ADULT STEM CELL FUNCTION AND MUTATIONAL BURDEN IN CANCER STEM CELLS.- Next generation sequencing for drug designing and development: An Omics approach for cancer treatment- The Lagging Strand: Genome Therapeutics and Their Implementation.- Cancer Evolution and Immune Evasion : Determinism and cancer progression- Determinants of immunological response to immune checkpoint blockade in human cancer

Topics


Dr Fatmaa abdel KerimAsistant consultant of tissue culture

Dr Sara HassanConsultant of clinical pathology

Dr omayma HassanienConsultant of clinical pathology

Dr. Amany MaherConsultant of clinical pathology

Dr. Sawsan MahmoudFellow of Biochemistry, MASRI

- Cancer epigenetics and genome regulation at single cell resolution- Identification of (neo)antigenic landscape of human tumors- Deciphering intra-tumor and inter-tumor heterogeneity by single cell RNA-seq- Human Genetics at a Crossroads: From Discovery to Interpretation and Implementation- Cancer and microenvironment: immunogenomics and single cells- «Real-World Implementation of Precision Health: Using Genomics to Drive Patient Engagement and Health Outcomes»

Proteomics & Metabolomics :• Current trends in Proteomics• Mass spectrometry in Proteomics• Proteomics in Molecular Medicine• Application of Proteomics• Cancer Proteome and biomakers• Current trends in Metabolomic• Clinical Metabolomic• Therapeutic Metabolomics• Mass spectrometry in Metabolomics• Metabolic profiling and fingerprinting• Analytical techniques in MetabolomicsBioinformatics workshop:• Introduction to Bioinformatics• Analysis of cancer repository data• Introduction to Metagenomic Analysis.• Radiogenomics• Introduction to Drug Design• Proteomics in drug discovery• Proteome informatics• Metabolomic informatics• Computational methodologies in Metabolomics• Medical Informatics and Machine Learning

Prof.Ahmed SultanAdjunct Professor, Oncology Department, LCCC, Georgetown University Medical Center,Washington DC, USA

Prof. Gengis Yakicier Head of Molecular Biology and Genetic Daprtment Acebadim UniversityTurkey



Personalization

Precision

& Perfection

Main Topics- Principles of organ Transplntaion - Indications for liver Transplntaion and proper timing - Preoperative preparation:donors issues- Preoperative preparation:recipients issues- Postoperative medical complications - Postoperative surgical complications

Transplantation Course

Prof. Mohamed FathyPast Dean of National Liver Institute Professor of Hepatobiliary SurgeryAin Shams University

Course Director



USING STATISTICAL ANALYSIS IN ACADEMIC RESEARCH

Prof. Philip RoweSchool of Pharmacy & Biomolecular Sciences

UK

Dr. Khaled Abdel Aziz


AIMS This course aims to provide a better understanding of:• Random sampling error• Confidence Intervals• P-values• Statistical Tests• Samples Size• Clinical Significance • Statistical Significance• Reporting Statistical Procedur

Pre Registration is

required

Bringing a laptop

is mandatory

Software is not

compatible with

Apple


Personalization

Precision

& Perfection

In collaboration with the Tumori Journal, for the first time in the Middle east The accepted abstracts will be internationally published in special supplement with JIF 1.304. (Tumori journal with impact factor 1.233)www.tumorijournal.com

Call for AbstractsThe abstract deadline is 10th March 2020.

Oral Presentations:Select abstracts, chosen by the Program Committee, will be presented as an oral presentation. Complete information (including presentation details, poster dimensions, etc.) will be provided after acceptance notification.

Poster Presentations: All accepted abstracts will be displayed as posters throughout the meeting. Complete information (including poster dimensions) will be provided after acceptance notification. Please read carefully before submission as abstracts that do not follow the criteria will not be reviewed 1- Abstracts must be supplied as a word file in their final order. 2- It is not possible to reorder them once they have been processed. 3- Abstracts will NOT undergo copy-edi/ng or style edi/ng. 4- The submitting person will receive email confirmation of receive.5- Each abstract must not exceed 350 words and must be structured as follows: TITLE IN BOLD CAPITAL LETTERS Authors list, with Surname and Initials (Smith GH), affiliations identified with superscripts (e.g. Smith GH1) Affiliations for each author, as Department, Hospital/University, City, and Country.6- Abstract, structure should be in the following format (Introduction, Material and Methods, Results, Conclusions). 7- No figures, tables and references will be accepted. 8- You should indicate the Presenting author (usually it is underlined).

ABSTRACT SUBMISSION:by mail, [email protected]. The Program Committee members will review your abstract,and you will be notified of their decision by 1st April, 2020.If you have any questions about the above guidelines, please contact,Dr. Nermean Mostafa, Mobile: +201229000721E-mail : [email protected] or [email protected]



Documents

International GastroIntestinal, Liver & Uro-Oncology Conference … · 2020-05-04 · 10 9 th International GastroIntestinal Liver & Uro-Oncology Conference Prof. Gengis Yakicier